PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback